Journey Medical Corporation IPO Research Information

Journey Medical Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Journey Medical Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Journey Medical Corporation	DERM - NASDAQ	$10.00-$12.00	$10.00	$8.70	3.5 million	11/12/2021
Underwriter(s): B. Riley Securities
Co-Manager(s): Roth Capital
Industry: Health Care
Filing(s): Filed 2021-10-22 Terms Added 2021-11-09

Journey Medical Corporation Quote & Chart - Click for current quote - DERM

About Journey Medical Corporation (adapted from Journey Medical Corporation prospectus):
Journey Medical Corporation is a commercial-stage pharmaceutical company founded in October 2014 that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "DERM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.